marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-07-2024
Magenta Therapeutics Income Statement 2011-2024 | MGTA
Annual Income Statement Magenta Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
3.61 M | 664 K | 173 M | 427 M | 455 M | 126 M | - | - | - | - | - | - | - |
Shares |
5.15 M | 874 K | 54.9 M | 48.4 M | 37 M | 18.4 M | - | - | - | - | - | - | - |
Historical Prices |
0.7 | 0.76 | 3.15 | 10.5 | 11.8 | 13.1 | - | - | - | - | - | - | - |
Net Income |
-43.6 M | -28.5 M | -71.1 M | -74.9 M | -76.8 M | -57.5 M | -35.5 M | -9.43 M | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-48.2 M | -29.7 M | -74.7 M | -78.7 M | -83 M | -60 M | -35.7 M | -9.27 M | - | - | - | - | - |
Interest Expense |
-60 K | -52 K | - | - | - | - | - | 163 K | - | - | - | - | - |
EBITDA |
-48.1 M | -29.7 M | -72.7 M | -76.7 M | -81.1 M | -59.1 M | -35.1 M | -9.26 M | - | - | - | - | - |
Operating Expenses |
51 M | 36.1 M | 74.7 M | 78.7 M | 83 M | 60 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
18.2 M | 6.74 M | 27.9 M | 28.1 M | 23.8 M | 18.6 M | 7.83 M | 3.49 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Magenta Therapeutics
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
34.2 M | 34.2 M | 25.7 M | 14.8 M | 3.91 M | 875 K | 875 K | 875 K | 874 K | 58.8 M | 58.8 M | 58.8 M | 58.6 M | 53.7 M | 48.6 M | 48.5 M | 48.3 M | 39.6 M | 39.4 M | 39.3 M | 38.8 M | 36.7 M | 33.4 M | 33.3 M | 33 M | 4.39 M | 2.47 M | 2.35 M | 2.01 M | 1.73 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-25.2 M | -17.6 M | -13.7 M | - | -14.8 M | -11.1 M | -7.09 M | - | -7.78 M | -17.3 M | -23 M | - | -17.4 M | -16.9 M | -17.5 M | - | -74.9 M | -74.9 M | -74.9 M | -23.2 M | -76.8 M | -76.8 M | -76.8 M | -16.7 M | -57.5 M | -57.5 M | -57.5 M | -8.04 M | 35.5 M | 35.5 M | -4.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | 924 K | - | - | - | 1.17 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-29.9 M | -22.2 M | -17.8 M | - | -15.8 M | -11.8 M | -7.68 M | - | -8.25 M | -18.1 M | -23.8 M | - | -18.2 M | -17.6 M | -18.7 M | - | -18.4 M | -20 M | -21.2 M | -24.6 M | -22.6 M | -19.3 M | -16.4 M | -17.9 M | -16.7 M | -14 M | -11.3 M | -8.17 M | -7.02 M | -15.7 M | -4.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
22 K | -80 K | -114 K | - | -15 K | -23 K | -3 K | - | -2 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-29.9 M | -22.2 M | -17.8 M | - | -15.7 M | -11.8 M | -7.67 M | - | -8.25 M | -18.1 M | -23.3 M | - | -16.8 M | -17.6 M | -18.2 M | - | -16.9 M | -19 M | -20.8 M | -24.6 M | -21.3 M | -18.5 M | -15.9 M | -17.9 M | -16.2 M | -13.7 M | -11.2 M | -8.17 M | -6.77 M | -15.6 M | -4.81 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
32.1 M | 24.1 M | 18.7 M | - | 16.7 M | 12.7 M | 8.16 M | - | 9.43 M | 18.1 M | 23.8 M | - | 18.2 M | 17.6 M | 18.7 M | - | 18.4 M | 20 M | 21.2 M | - | 22.6 M | 19.3 M | 16.4 M | - | 16.7 M | 14 M | 11.3 M | - | 7.02 M | 15.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
6.53 M | 6 M | 5.64 M | - | 8.72 M | 2.49 M | 2.31 M | - | 2.21 M | 6.48 M | 7.29 M | - | 7.45 M | 6.48 M | 6.97 M | - | 6.6 M | 7.4 M | 7.28 M | - | 6.12 M | 5.9 M | 5.81 M | - | 5.28 M | 4.34 M | 3.46 M | - | 1.8 M | 1.92 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency